MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
16.54
-0.04 (-0.27%)
May 26, 2026, 2:50 PM EDT - Market open
MediWound Market Cap
MediWound has a market cap or net worth of $212.51 million as of May 26, 2026. Its market cap has increased by 12.62% in one year.
Market Cap
212.51M
Enterprise Value
169.75M
1-Year Change
12.62%
Ranking
Category
Stock Price
$16.54
Market Cap Chart
Since March 20, 2014, MediWound's market cap has decreased from $262.70M to $212.51M, a decrease of -19.10%. That is a compound annual growth rate of -1.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 213.09M | -9.97% |
| Dec 31, 2025 | 236.68M | 23.23% |
| Dec 31, 2024 | 192.06M | 104.85% |
| Dec 29, 2023 | 93.76M | 19.44% |
| Dec 30, 2022 | 78.50M | 22.08% |
| Dec 31, 2021 | 64.30M | -36.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Codexis | 226.33M |
| Atrium Therapeutics | 223.91M |
| Whitehawk Therapeutics | 221.93M |
| Keros Therapeutics | 221.47M |
| NervGen Pharma | 218.26M |
| Nkarta | 216.78M |
| Unicycive Therapeutics | 215.74M |
| Caribou Biosciences | 206.34M |